Toxic risk of stereotactic body radiotherapy and concurrent helical tomotherapy followed by erlotinib for non-small-cell lung cancer treatment - case report

被引：0
|
作者：
Chen-Hsi Hsieh
Hou-Tai Chang
Shih-Chiang Lin
Yu-Jen Chen
Li-Ying Wang
Yen-Ping Hsieh
Chien-An Chen
Ngot-Swan Chong
Shoei Long Lin
Chun-Yi Chen
Pei-Wei Shueng
机构：
[1] Far Eastern Memorial Hospital,Department of Radiation Oncology
[2] Far Eastern Memorial Hospital,Department of Chest Medicine, Division of Internal Medicine
[3] Far Eastern Memorial Hospital,Department of hematology
[4] National Defense Medical Center,Department of Radiation Oncology
[5] National Yang-Ming University,Institutes of Traditional Medicine, School of Medicine
[6] Mackay Memorial Hospital,Department of Radiation Oncology
[7] National Taiwan University,School and Graduate Institute of Physical Therapy, College of Medicine
[8] Asia University,Department of Healthcare Administration
[9] Taipei Hospital,Department of Surgery, Department of Health
[10] Taipei Hospital,Division of Medical Oncology, Department of Internal Medicine, Department of Health
来源：
BMC Cancer | / 10卷
关键词：
Epidermal Growth Factor Receptor; Erlotinib; Interstitial Lung Disease; NSCLC Patient; Stereotactic Body Radiation Therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Toxic risk of stereotactic body radiotherapy and concurrent helical tomotherapy followed by erlotinib for non-small-cell lung cancer treatment - case report
    Hsieh, Chen-Hsi
    Chang, Hou-Tai
    Lin, Shih-Chiang
    Chen, Yu-Jen
    Wang, Li-Ying
    Hsieh, Yen-Ping
    Chen, Chien-An
    Chong, Ngot-Swan
    Lin, Shoei Long
    Chen, Chun-Yi
    Shueng, Pei-Wei
    BMC CANCER, 2010, 10
  • [2] PROGNOSTIC FACTORS IN STEREOTACTIC BODY RADIOTHERAPY FOR NON-SMALL-CELL LUNG CANCER
    Matsuo, Yukinori
    Shibuya, Keiko
    Nagata, Yasushi
    Takayama, Kenji
    Norihisa, Yoshiki
    Mizowaki, Takashi
    Narabayashi, Masaru
    Sakanaka, Katsuyuki
    Hiraoka, Masahiro
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (04): : 1104 - 1111
  • [3] Erlotinib in the treatment of non-small-cell lung cancer
    Kyte, J.
    Wilson, P. C.
    Dangoor, A.
    LUNG CANCER, 2012, 75 : S6 - S7
  • [4] Treatment Outcomes and Toxicities of Stereotactic Body Radiotherapy for Oligoprogressive Metastatic Non-Small-Cell Lung Cancer
    Wong, K. K. S.
    Kam, T. Y.
    Yeung, M. W.
    Soong, S. I.
    HONG KONG JOURNAL OF RADIOLOGY, 2023, 26 (04): : 248 - 254
  • [5] FEASIBILITY OF HELICAL TOMOTHERAPY IN STEREOTACTIC BODY RADIATION THERAPY FOR CENTRALLY LOCATED EARLY STAGE NON-SMALL-CELL LUNG CANCER OR LUNG METASTASES
    Chi, Alexander
    Jang, Si Young
    Welsh, James S.
    Nguyen, Nam P.
    Ong, Evan
    Gobar, Lisa
    Komaki, Ritsuko
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (03): : 856 - 862
  • [6] Special Report: Policy Erlotinib for the treatment of non-small-cell lung cancer
    Kandaswamy, Prashanth
    Boysen, Meindert
    Longson, Carole
    Stevens, Andrew
    LANCET ONCOLOGY, 2009, 10 (01): : 15 - 16
  • [7] Stereotactic body radiotherapy compared with surgery in non-small-cell lung cancer patients
    Crisp, Alisa
    LUNG CANCER MANAGEMENT, 2013, 2 (02) : 95 - 96
  • [8] Radiation Pneumonitis in Patients with Non-Small-Cell Lung Cancer Treated with Erlotinib Concurrent with Thoracic Radiotherapy
    Zhuang, Hongqing
    Yuan, Zhiyong
    Chang, Joe Y.
    Wang, Jun
    Pang, Qingsong
    Zhao, Lujun
    Wang, Ping
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (06) : 882 - 885
  • [9] Stereotactic Radiotherapy as Salvage Treatment after Stereotactic Radiotherapy or after Operated Non-Small-Cell Lung Cancer
    Kristiansen, Charlotte
    Schytte, Tine
    Jeppesen, Stefan S.
    Hansen, Olfred
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S443 - S443
  • [10] Definitive radiotherapy with concurrent oncothermia for stage IIIB non-small-cell lung cancer: A case report
    Yeo, Seung-Gu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 10 (02) : 769 - 772
12345